Clinical Trial Update: Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLC

View source ↗

Summary

A multicenter observational prospective study in advanced non-small cell lung cancer to determine the incidence of HER2 mutations and assess therapeutic managem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica | Conditions: NSCLC (Advanced Non-small Cell Lung Cancer), HER2 | Status: RECRUITING